TPG Tests IPO Appetite

TPG went public today, ringing in the first IPO of 2022. 🔔 TPG opened 12% above its offering price, valuing the company at $12 billion.

TPG announced it would sell its shares at the midpoint of its price range last night, which we reported to be $29.50. However, by the end of the day, the private equity firm had risen 15.3%, hitting $34.00/share. The company’s shares enjoyed those gains even amidst weakness in the Nasdaq Composite, which was down 2.5% today.

On some level, TPG’s IPO success might invite concerns that America’s IPO pipeline could freeze up during the Fed’s ongoing macro campaign. Major indexes have appreciated considerable corrections from their end-of-year prices, which has been enough to scare some companies from testing their own market debuts — namely Justworks, which decided to punt its IPO given concerns about the health of the markets. 👋

However, in fairness to Justworks and other companies, TPG is a diversified giant — and other P/E rivals like Blackstone and KKR have bested the S&P 500. Although TPG still has to prove its worth (the company only makes $109 billion in assets, a fraction of its competitors), the company’s success today indicates investors’ appetite for healthy risk in the markets. 📈

Hop in and join the conversation on the $TPG Stocktwits stream.

Learn More About...

Nio & Nikola’s Never-Ending Story

No matter the day, there seems to be an endless stream of electric vehicle (EV) industry news. Let’s get into today’s headlines. 📰

First up is China’s Nio, which just received an additional $2.2 billion investment from Abu Dhabi’s CYVN Holdings, which raised its stake to 20.1%. The fund had last invested in Nio during July, with a $1 billion investment. 

Read It

Plug Power Is Charged Up

Plug Power hasn’t given investors much to be excited about over the last few years, but today’s news has people (and its stock price) charged up again. So let’s see what happened. 👇

The alternative-energy company, which provides hydrogen fuel cell technology, finalized a deal with the Department of Energy (DOE) for a $1.6 billion loan facility. This critical funding comes at a time when the company has faced immense liquidity issues, issuing a going-corn warning last quarter and disclosing a secondary share offering of up to $1 billion. 💸

Read It

Pfizer’s Flop Continues

It’s been a rough ride for pharmaceutical giant Pfizer since the end of the pandemic, and that rollercoaster ride continues today. 🎢

The company last announced earnings in October but needed to update Wall Street on its 2024 forecast. It cited weak demand for its Covid products as the reason for a weaker-than-anticipated revenue and earnings forecast.

Read It

Investors Are Losing Trust

It’s been a rough eighteen months or so for real estate investment trusts (REITs), with higher interest rates giving investors alternative sources of yield and pressuring commercial real estate’s asset values. Unfortunately for Medical Properties Trust (MPT), that pain continues today, with its shares falling back to their Great-Financial-Crisis lows. 😬

The medical-related real estate property operator revealed to investors that one of its tenants, Steward Health Care System, is roughly $50 million behind in rent payments. As a result, MPT will take a $225 million noncash charge to write off rent receivables and other items. 

Read It